PubMed

Antiviral therapy in acute viral hepatitis B: why and when.

Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O.

Infect Agent Cancer. 2009 Jan 16;4:2.PMID: 19149879 [PubMed]Free PMC ArticleFree textRelated citations

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS.

J Immunol. 2006 Jul 1;177(1):739-47.PMID: 16785573 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.PMID: 11982721 [PubMed - indexed for MEDLINE]Related citations

Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.

Safadi R, Israeli E, Papo O, Shibolet O, Melhem A, Bloch A, Rowe M, Alper R, Klein A, Hemed N, Segol O, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Am J Gastroenterol. 2003 Nov;98(11):2505-15.PMID: 14638356 [PubMed - indexed for MEDLINE]Related citations

[Immunopathology of chronic liver diseases]

Meyer zum Büschenfelde KH.

Verh Dtsch Ges Pathol. 1995;79:186-97. Review. German. PMID: 8600684 [PubMed - indexed for MEDLINE]Related citations

Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.

Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS.

Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3. Epub 2008 Mar 22.PMID: 18455515 [PubMed - indexed for MEDLINE]Related citations

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.PMID: 18663260 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Hepatitis B virus immunopathogenesis.

Chisari FV, Ferrari C.

Annu Rev Immunol. 1995;13:29-60. Review.PMID: 7612225 [PubMed - indexed for MEDLINE]Related citations

Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection.

Sainokami S, Abe K, Sato A, Endo R, Takikawa Y, Suzuki K, Okamoto H.

J Gastroenterol. 2007 Mar;42(3):241-9. Epub 2007 Mar 30.PMID: 17380283 [PubMed - indexed for MEDLINE]Related citations

Pathogenesis of hepatitis B virus infection.

Baumert TF, Thimme R, von Weizsäcker F.

World J Gastroenterol. 2007 Jan 7;13(1):82-90. Review.PMID: 17206757 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Hepatitis B virus immunopathology.

Chisari FV, Ferrari C.

Springer Semin Immunopathol. 1995;17(2-3):261-81. Review.PMID: 8571172 [PubMed - indexed for MEDLINE]Related citations

Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.

Marinos G, Naoumov NV, Williams R.

Hepatology. 1996 Nov;24(5):991-5.PMID: 8903365 [PubMed - indexed for MEDLINE]Related citations

Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.

Ozasa A, Tanaka Y, Orito E, Sugiyama M, Kang JH, Hige S, Kuramitsu T, Suzuki K, Tanaka E, Okada S, Tokita H, Asahina Y, Inoue K, Kakumu S, Okanoue T, Murawaki Y, Hino K, Onji M, Yatsuhashi H, Sakugawa H, Miyakawa Y, Ueda R, Mizokami M.

Hepatology. 2006 Aug;44(2):326-34.PMID: 16871568 [PubMed - indexed for MEDLINE]Related citations

Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.

Chisari FV.

Curr Top Microbiol Immunol. 1996;206:149-73. Review.PMID: 8608715 [PubMed - indexed for MEDLINE]Related citations

A virological perspective on the need for vaccination.

Locarnini S.

J Viral Hepat. 2000 May;7 Suppl 1:5-6. Review.PMID: 10866836 [PubMed - indexed for MEDLINE]Related citations

Role of viral factors in the natural course and therapy of chronic hepatitis B.

Kao JH.

Hepatol Int. 2007 Dec;1(4):415-30. Epub 2007 Oct 12.PMID: 19669337 [PubMed - in process]Free PMC ArticleFree textRelated citations

Cellular immune responses to the hepatitis B virus polymerase.

Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, Rehermann B.

J Immunol. 2004 Nov 1;173(9):5863-71.PMID: 15494540 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection.

Hodgson PD, Michalak TI.

Hepatology. 2001 Nov;34(5):1049-59.PMID: 11679978 [PubMed - indexed for MEDLINE]Related citations

Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.

Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F, Trépo C.

J Med Virol. 2007 Aug;79(8):1075-81.PMID: 17596829 [PubMed - indexed for MEDLINE]Related citations

Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.

Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z.

Immunology. 2008 Jan;123(1):57-65. Epub 2007 Aug 31.PMID: 17764450 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations